Carla Chaney - May 31, 2024 Form 4 Insider Report for EQUIFAX INC (EFX)

Role
EVP, Chief HR Officer
Signature
/s/Lisa Stockard as Attorney-in-Fact
Stock symbol
EFX
Transactions as of
May 31, 2024
Transactions value $
-$217,704
Form type
4
Date filed
6/4/2024, 04:13 PM
Previous filing
May 29, 2024
Next filing
Aug 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFX Common Stock Options Exercise $720K +4.1K +24.31% $175.48 21K May 31, 2024 Direct F1, F2
transaction EFX Common Stock Sale -$51.1K -223 -1.06% $229.20 20.8K May 31, 2024 Direct F1, F2, F3
transaction EFX Common Stock Sale -$357K -1.56K -7.53% $228.04 19.2K May 31, 2024 Direct F1, F2, F4
transaction EFX Common Stock Sale -$530K -2.32K -12.07% $228.79 16.9K May 31, 2024 Direct F1, F2, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFX Stock Option/Right to Buy Options Exercise $0 -4.1K -100% $0.00* 0 May 31, 2024 Common Stock 4.1K $175.48 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024.
F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $228.85 to $229.525, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $227.445 to $228.435, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $228.44 to $229.29, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F6 The option vested in three equal annual increments beginning 2/21/2021.